— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.
— Net sales remained flat at $70 million, vs. $71.2 million expected.
— US net sales grew 1.8% to $55.6 million.
— International net sales increased 5.6% to $14.4 million.
— Oncology net sales rose 5.1% to $16.1 million.
— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.
— Vascular Access net sales fell 4% to $22.8 million.
— FY2020 net sales are expected to be $280-286 million.
— FY2020 adjusted EPS is expected to be $0.10-0.15.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
360 DigiTech (NASDAQ: QFIN) Q3 2021 Research Summary
The positive effects of widespread digitalization and e-commerce growth on China’s financial services industry became more pronounced during the pandemic as the movement restrictions drove more retail customers to online
Activision Blizzard (ATVI): Three reasons why this stock deserves to be on your radar
Shares of Activision Blizzard Inc. (NASDAQ: ATVI) were up 1.6% on Thursday. The stock has dropped 14% since the start of the year. The company has been in the news
IPO Alert: Here’s all you need to know about Remitly Global’s upcoming market debut
The emergence of technology-driven financial services is making people think beyond conventional banks when it comes to availing loans and transferring funds. In a move aimed at taking its business
